The MRC Clinical Trials Unit (MRC CTU) at UCL is at the forefront of resolving internationally important questions in infectious diseases and cancer, and delivering swifter and more effective translation of scientific research into patient benefits.
The 50th Union World Conference on Lung Health
MRC Clinical Trials Unit at UCL will be presenting results from the STREAM tuberculosis trial.
STAMPEDE provides further insight into treating prostate cancer
Further results from the STAMPEDE trial have been presented at European Society for Medical Oncology Congress 2019 over the last few days
Active observation still the best treatment for kidney cancer patients at medium or high risk of their cancer coming back after surgery
Active observation remains the best treatment for patients who are at medium or high risk of their cancer coming back after surgery to remove their kidney cancer.
More men with prostate cancer can be spared radiotherapy after surgery
The RADICALS-RT trial looked at 1396 men with prostate cancer after they had surgery to remove the cancer.
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Major international clinical trials answering questions of global public health significance
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes
Results from the TRACT trial - Giving the right amount of blood in transfusions can halve deaths among children with severe anaemia #clinicaltrials #TRACTtrial https://t.co/AU8F0WMhM1 https://t.co/OYwUFtvNpI